Top news of the week: 06.05.2021.
Career And Jobs
Changing of the Guard: Four Biopharma Companies Appoint New CEOs
Companies across the biotech and biopharma industries recently reported a slew of new leadership appointments, several of which have been explicitly focused on the fields of oncology and ...
Entrada Therapeutics Appoints Biotech Industry Leader Mary Thistle to Its Board of Directors
BOSTON--(BUSINESS WIRE)--Entrada Therapeutics, Inc., a biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced ...
'Changing the whole game of drug discovery': legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO
Roger Perlmutter needs no introduction to anyone remotely involved in biopharma. As the R&D chief first at Amgen and then Merck, he’s built a stellar reputation and a prolific career ...
Evaluate Acquires Bioscience Advisors, Adding the Most Comprehensive Database of Biopharma Deals to Its Commercial Intelligence Portfolio
LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--#biopharma--Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to ...
Original Vaccitech investor: Biotech no COVID one-hit wonder, as IPO injects $110M for broad pipeline
As Vaccitech prices a $110.5 million IPO, one investor says the company has a pipeline that could address a number of killer diseases long after the headlines over the AstraZeneca vaccine’s ...
Fourth Annual Best of Benchmark Award Winners Announced
The Awards are Given for Commercial Operations Excellence within the Pharmaceutical IndustryWALTHAM, Mass.--(BUSINESS WIRE)--#Benchmarking--Trinity Life Sciences, a leader in global life ...
Graphite Bio Appoints Dr. Kristen Hege, Smital Shah and Dr. Jo Viney to Board of Directors
Experienced biopharma executives with decades of scientific and business leadership expertise join as members of the boardSOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
Josh Bilenker and Jeff Engelman bundle a mother lode of cash for their stealthy startup, attracting a who's who of biotech investors
Josh Bilenker and Jeff Engelman won’t be worrying about money for their stealthy startup anytime soon. Late last week the pair filed a Form D for their new biotech Treeline Biosciences ...